The largest database of trusted experimental protocols

Ultimate 3000 rslcnano hplc

Manufactured by Thermo Fisher Scientific
Sourced in Germany

The Ultimate 3000 RSLCnano HPLC is a high-performance liquid chromatography system designed for nano-scale separations. It features a flow rate range of 50 nL/min to 2 μL/min, a pressure range up to 800 bar, and a temperature range up to 65°C. The system is equipped with a state-of-the-art autosampler and a column compartment to ensure precise and reproducible results.

Automatically generated - may contain errors

21 protocols using ultimate 3000 rslcnano hplc

1

Quantitative Proteomic Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples for global analysis were fractionated after digestion and subjected to LC-MS/MS analysis using an Ultimate 3000 RSLCnano HPLC coupled to a Q Exactive HF mass spectrometer, while samples dedicated to label-free quantification and PRM analysis were measured unfractionated on an Ultimate 3000 RSLCnano HPLC coupled to an Orbitrap Fusion Lumos mass spectrometer (all from Thermo Scientific). Detailed settings are described in Text S1 in the supplemental material.
+ Open protocol
+ Expand
2

Comprehensive DIA-based Plasma Proteomics

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasma samples from 171 patients who were enrolled in the participating centers in Bochum and Bonn were digested according to the SP3 protocol with slight modifications. Briefly, 100 µg protein was purified using paramagnetic beads (Cytiva Sera-Mag Carboxyl-Magnet-Beads, GE Healthcare, Chicago, IL) and digested overnight using trypsin (SERVA Electrophoresis, Heidelberg, Germany). Subsequently, 300 ng tryptic peptides per sample were analyzed using an Ultimate 3000 RSLCnano HPLC coupled online to either an Orbitrap QExactive, Orbitrap QExactive HF, or Orbitrap Fusion Lumos mass spectrometer (all Thermo Scientific, Bremen, Germany). In total, 306 samples were analyzed and distributed over five batches and separated by either a 96-min (Batch 1) or 38-min (Batches 2–5) LC gradient. The mass spectrometers were operated in data-independent acquisition mode. Spectral libraries were generated with FragPipe (v.17.1) and protein quantification was conducted using DIA-NN (v.1.8) [30 (link)]. The Uniprot/SwissProt database restricted to homo-sapiens (release 01_2022; 20,386 entries) was used for protein identification. The resulting protein intensities were first normalized using the LOESS method [31 (link)]. The subsequent cross-batch normalization was based on linear regression models. A detailed description of the applied methods can be found in the Additional file.
+ Open protocol
+ Expand
3

Nanoflow LC-MS/MS Peptide Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concatenated fractions were vacuum concentrated once more until approximately 5 μL and then reconstituted to a total volume of 30 μL with 0.1% (v/v) formic acid (FA), sonicated in a water bath for 15 min and centrifuged at 16000 x g for 10 min to remove particulates. Using an Ultimate 3000 RSLCnano HPLC (Thermo Scientific), each sample was loaded via a trap column (100 μm x 2 cm nanoViper PepMap 100; Thermo Scientific) in 2% (v/v) ACN, 0.1% (v/v) FA at a flow rate of 15 μL/min onto an analytical nanocolumn (75 μm x 50 cm PepMap 100 C18 3 μm 100Å; Thermo Scientific) at a flow rate of 300 μL/min. Peptides were separated using increasing concentrations of 80% (v/v) ACN, 0.1% (v/v) FA (buffer B) (2.5% B to 42.5% B over 20 min) and analysed with a Q Exactive Hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Scientific). Up to 12 MS/MS spectra were acquired per cycle with maximum accumulation time of 50 ms and 100 ms for MS1 and MS2, respectively. To prevent multiple sequencing of the same peptide (dynamic exclusion), MS1 masses were excluded for 10 secs.
+ Open protocol
+ Expand
4

Label-free Quantification of Oyster Proteome

Check if the same lab product or an alternative is used in the 5 most similar protocols
The eluted peptides were analysed with an LTQ Orbitrap Elite (Thermo Fisher Scientific, Melbourne, VIC, Australia) with a Nano ESI interface in conjunction with an Ultimate 3000 RSLC nano-HPLC (Dionex Ultimate 3000, Thermo Fisher Scientific, Melbourne, VIC, Australia) at the Bio21 Institute, Melbourne, Australia following the procedure described in [5 (link)]. Label free quantification was conducted for the proteins in each extraction buffer using MaxQuant 1.6.5.0 [13 (link)] complemented with the Andromeda Search engine and searched against the in-house database of the oyster proteome downloaded from the UniProt (https://www.uniprot.org/proteomes/UP000005408). The approximate abundance of the proteins was calculated using iBAQ algorithm [14 (link)], which measures the intensity of each protein by summing up the precursor peptides of that protein and dividing it by the number of theoretically observable peptides. The absolute amount of each protein in each extract was determined by dividing the protein’s iBAQ value by the sum of all non-contaminant iBAQ values, generating an riBAQ value for each protein and a normalized measure of molar abundance (relative iBAQ): riBAQ = iBAQii = 1niBAQi
+ Open protocol
+ Expand
5

Proteomic Analysis of TMT-labeled Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
TMT‐labeled peptide from each sample was analyzed by nanoflow liquid chromatography electrospray tandem mass spectrometry using a Thermo Ultimate 3000 RSLCnano HPLC autosampler system coupled to an Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific). Peptides (500 ng) were loaded on a 33 μL EXP stem trap packed with HALO C18 resin (2.7 μM, 90 Å, Optimize Technologies). Peptides were eluted at a flow rate of 350 ηL/min from the trap through a 100 μm × 30 cm PicoFrit column (New Objective) packed in‐house with Acclaim Pepmap C18 resin (Thermo Fisher). Chromatography was performed using a 2% to 35% gradient of Solvent B over 120 min (Solvent A: 98% water/2% acetonitrile/0.2% formic acid, Solvent B: 80% acetonitrile/10% isopropanol/10% water/0.2% formic acid). The Fusion Lumos mass spectrometer was set to acquire ms1 survey scans from 340 to 1600 m/z at a resolution of 120,000 (at 200 m/z) with the automatic gain target (AGC) set at 4e5 ions and a maximum ion inject time of 50 ms. Survey scans were followed by ms2 high energy collision dissociation (HCD) set at 38%, resolution of 50,000 (at 200 m/z), an AGC target of 1e5 ions, a maximum ion inject time of 120 ms, and the isolation window set at 0.07 Da. Dynamic exclusion placed selected ions on an exclusion list for 60 s.
+ Open protocol
+ Expand
6

DARTS Assay for Target Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug affinity responsive target stability (DARTS) assay was completed to identify the target of ISP I in vitro. For this assay, we used the protocol published by Lomenick et al. [19 (link)]. Briefly, LN229 cells were lysed with M-PER (Pierce) and supplemented with protease and phosphatase inhibitors. After centrifugation at 14, 000 rpm for 15 min, lysates were diluted to the same final volume and protein concentration with M-PER and proposed in TNC buffer [50 mM Tris·HCl (pH 8.0), 50 mM NaCl, 10 mM CaCl2]. All steps were performed on ice or at 4 °C to prevent premature protein degradation. After incubation, the protein sample was incubated with ISP I (40 μM) or DMSO (control) at room temperature for one hour. Each sample was subsequently proteolyzed with 2 μL 1:100 Pronase at room temperature for 32 min. To stop proteolysis, 3 μL cold 20 × Protease inhibitor was added to each sample, mixed, and placed on ice. The digested peptides were filtered through Vivacon 500 10 K spin column, precipitated using acetone, reduced with TCEP, alkylated with NEM, and digested with trypsin. Digests were desalted and used for LC–MS/MS data acquisition on an Orbitrap Lumos mass spectrometer (Thermo Fisher Scientific) coupled with an UltiMate 3000 RSLC-nano HPLC (Thermo Fisher Scientific) in data-dependent acquisition (DDA) mode.
+ Open protocol
+ Expand
7

Sensitive LC-MS/MS Proteomics Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC-MS/MS data were collected on Q-Exactive (QE) High Field (HF) Hybrid Quadrupole Orbitrap MS (Thermo Fisher Scientific) coupled with an UltiMate 3000 RSLCnano HPLC and a Nano-spray Flex ion source (Thermo Fisher Scientific) using a standard data-dependent acquisition. Peptides (1 µg) were loaded onto a trap column (300 µm ID × 5 mm, 5 µm 100 Å PepMap C18 medium) and then separated on a 15-cm long Acclaim™ PepMap™ (75 µm, 3μm 100 Å PepMap C18 medium, Thermo Fisher Scientific) analytical column. All the MS measurements were performed in the positive ion mode using 120 min LC gradient method as described elsewhere61 (link),62 (link), MS data were collected using Top20 data dependent MS/MS scan method.
+ Open protocol
+ Expand
8

Comprehensive DIA-based Plasma Proteomics

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasma samples from 171 patients who were enrolled in the participating centers in Bochum and Bonn were digested according to the SP3 protocol with slight modifications. Briefly, 100 µg protein was purified using paramagnetic beads (Cytiva Sera-Mag Carboxyl-Magnet-Beads, GE Healthcare, Chicago, IL) and digested overnight using trypsin (SERVA Electrophoresis, Heidelberg, Germany). Subsequently, 300 ng tryptic peptides per sample were analyzed using an Ultimate 3000 RSLCnano HPLC coupled online to either an Orbitrap QExactive, Orbitrap QExactive HF, or Orbitrap Fusion Lumos mass spectrometer (all Thermo Scientific, Bremen, Germany). In total, 306 samples were analyzed and distributed over five batches and separated by either a 96-min (Batch 1) or 38-min (Batches 2–5) LC gradient. The mass spectrometers were operated in data-independent acquisition mode. Spectral libraries were generated with FragPipe (v.17.1) and protein quantification was conducted using DIA-NN (v.1.8) [30 (link)]. The Uniprot/SwissProt database restricted to homo-sapiens (release 01_2022; 20,386 entries) was used for protein identification. The resulting protein intensities were first normalized using the LOESS method [31 (link)]. The subsequent cross-batch normalization was based on linear regression models. A detailed description of the applied methods can be found in the Additional file.
+ Open protocol
+ Expand
9

Peptide Purification and Mass Spectrometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The procedure was essentially carried out as indicated in earlier work (16 (link)). In brief, following trypsin digestion, peptides were further cleaned using a C18 column and then injected into the UltiMate 3000 RSLC nano HPLC (Thermo Fisher Scientific). This HPLC system is linked to a Q Exactive HF mass spectrometer (Thermo Fisher Scientific) using a Proxeon Nanospray source (Thermo Fisher Scientific).
+ Open protocol
+ Expand
10

Plasma Proteome Profiling by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses were conducted as described before [22] . Briefly, plasma samples were prepared according to the SP3 protocol [23] and analyzed using an Ultimate 3000 RSLCnano HPLC coupled to an Orbitrap Exploris 240 mass spectrometer (both Thermo Scientific). The peptides were separated using a 37 min gradient from 4 to 28% acetonitrile in 0.1% formic acid and were measured using data independent acquisition. DIA-NN (v.1.8) was used for protein quantification with an in-house created spectral-library generated from plasma DDA measurements with FragPipe (v.17.1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!